Comparative effects of hydralazine on perfusion of kht tumor, kidney and liver and on renal function in mice

This publication has 19 references indexed in Scilit:

• Effects of Two Tumour Blood Flow Modifiers, Hydralazine and Flavone Acetic Acid, on KHT Tumours and Normal Tissues in Mice
  International Journal of Radiation Biology, 1991
• The energy metabolism of RIF-1 tumours following hydralazine
  Radiotherapy and Oncology, 1990
• Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine
  British Journal of Cancer, 1990
• Bioreductive drugs and the selective induction of tumour hypoxia
  British Journal of Cancer, 1990
• Manipulation of oxygenation in a human tumour xenograft with BW12C or hydralazine : effects on responses to radiation and to the bioreductive cytotoxicity of misonidazole or RSU-1069
  Radiotherapy and Oncology, 1989
• Renal function studies with cadralazine in conscious dogs: A comparison with hydralazine
  Pharmacological Research, 1989
• Winner of the 1988 Lund Science Award: Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinomain vivo
  International Journal of Hyperthermia, 1989
• Effects of Hydralazine-Induced Vasodilation on the Energy Metabolism of Murine Tumors Studied by In Vivo31P-Nuclear Magnetic Resonance Spectroscopy1
  JNCI Journal of the National Cancer Institute, 1988
• The effect of hydralazine on the tumor cytotoxicity of the hypoxic cell cytotoxin RSU-1069: Evidence for therapeutic gain
  International Journal of Radiation Oncology*Biology*Physics, 1987
• Effect of pH on Hyperthermic Cell Survival: Brief Communication 2
  JNCI Journal of the National Cancer Institute, 1977